Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
2001 1
2007 1
2016 1
2019 1
2020 1
2021 1
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for G. vesprini
Your search for G. Vesperini retrieved no results
Omitting Radiotherapy after Breast-Conserving Surgery in Luminal A Breast Cancer.
Whelan TJ, Smith S, Parpia S, Fyles AW, Bane A, Liu FF, Rakovitch E, Chang L, Stevens C, Bowen J, Provencher S, Théberge V, Mulligan AM, Kos Z, Akra MA, Voduc KD, Hijal T, Dayes IS, Pond G, Wright JR, Nielsen TO, Levine MN; LUMINA Study Investigators. Whelan TJ, et al. N Engl J Med. 2023 Aug 17;389(7):612-619. doi: 10.1056/NEJMoa2302344. N Engl J Med. 2023. PMID: 37585627
Mepitel Film for the Prevention of Acute Radiation Dermatitis in Breast Cancer: A Randomized Multicenter Open-Label Phase III Trial.
Behroozian T, Milton L, Karam I, Zhang L, Ding K, Lou J, Gallant F, Rakovitch E, Tran W, Soliman H, Leung E, Vesprini D, Szumacher E, Chen H, Donovan E, Lam J, Spadafora S, Wronski M, Lavoie C, Walde N, Lam E, Wong G, McKenzie E, Ariello K, Kennedy S, Shariati S, Carothers K, Gonzales G, Kagan Y, Chow E. Behroozian T, et al. J Clin Oncol. 2023 Feb 20;41(6):1250-1264. doi: 10.1200/JCO.22.01873. Epub 2022 Dec 9. J Clin Oncol. 2023. PMID: 36493331 Clinical Trial.
Stratification factors included surgery type, dose fractionation, and administration of boost/bolus. The primary end point was grade (G) 2 or 3 RD using the Common Terminology Criteria for Adverse Events v5.0. ...Benefits of MF remained significant in patients who develope …
Stratification factors included surgery type, dose fractionation, and administration of boost/bolus. The primary end point was grade (G …
Homologous recombination and prostate cancer: a model for novel DNA repair targets and therapies.
Bristow RG, Ozcelik H, Jalali F, Chan N, Vesprini D. Bristow RG, et al. Radiother Oncol. 2007 Jun;83(3):220-30. doi: 10.1016/j.radonc.2007.04.016. Epub 2007 May 24. Radiother Oncol. 2007. PMID: 17531338 Review.
Using elegant targeting techniques such as IMRT, radiation oncology has improved the therapeutic ratio of prostate cancer radiotherapy through increased physical precision (e.g. increased local control through dose-escalation without increased normal tissue toxicity). ...
Using elegant targeting techniques such as IMRT, radiation oncology has improved the therapeutic ratio of prostate cancer radiotherapy throu …
[Food knowledge of patients at the first access to a Diabetology center].
Petrelli F, Cangelosi G, Scuri S, Cuc Thi Thu N, Debernardi G, Benni A, Vesprini A, Rocchi R, De Carolis C, Pantanetti P, Faldetta F, Vita S, Talevi S, Capancioni A, Cerasoli G, Grappasonni I. Petrelli F, et al. Acta Biomed. 2020 Apr 10;91(3-S):160-164. doi: 10.23750/abm.v91i3-S.9418. Acta Biomed. 2020. PMID: 32275283 Free PMC article.
Minimizing the Risk of Acute Skin Toxicity Due to Hip Prosthesis Avoidance in Prostate Radiation Therapy.
Mak DY, Vesprini D, Davidson M. Mak DY, et al. Pract Radiat Oncol. 2023 Jan-Feb;13(1):66-70. doi: 10.1016/j.prro.2022.07.002. Epub 2022 Jul 27. Pract Radiat Oncol. 2023. PMID: 35907615
Avoidance efficiency is evaluated by recalculating the plan with prosthesis density set at 20 g/cc, and evaluating the loss of target coverage from increased attenuation. ...The plan with a skin D(max) of 40 Gy provides a better compromise between skin and prosthesis entra …
Avoidance efficiency is evaluated by recalculating the plan with prosthesis density set at 20 g/cc, and evaluating the loss of target …
Circulating miRNAs as non-invasive biomarkers to predict aggressive prostate cancer after radical prostatectomy.
Hoey C, Ahmed M, Fotouhi Ghiam A, Vesprini D, Huang X, Commisso K, Commisso A, Ray J, Fokas E, Loblaw DA, He HH, Liu SK. Hoey C, et al. J Transl Med. 2019 May 23;17(1):173. doi: 10.1186/s12967-019-1920-5. J Transl Med. 2019. PMID: 31122242 Free PMC article.
Patients were stratified into high- and low-risk categories based on Gleason score, pathological T stage, surgical margin status, and diagnostic PSA: patients with Gleason 8; pT3a and positive margin; pT3b and any margin; or diagnostic PSA > 20 g/mL were classified as h …
Patients were stratified into high- and low-risk categories based on Gleason score, pathological T stage, surgical margin status, and diagno …
Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment.
Jiang Y, Meyers TJ, Emeka AA, Cooley LF, Cooper PR, Lancki N, Helenowski I, Kachuri L, Lin DW, Stanford JL, Newcomb LF, Kolb S, Finelli A, Fleshner NE, Komisarenko M, Eastham JA, Ehdaie B, Benfante N, Logothetis CJ, Gregg JR, Perez CA, Garza S, Kim J, Marks LS, Delfin M, Barsa D, Vesprini D, Klotz LH, Loblaw A, Mamedov A, Goldenberg SL, Higano CS, Spillane M, Wu E, Carter HB, Pavlovich CP, Mamawala M, Landis T, Carroll PR, Chan JM, Cooperberg MR, Cowan JE, Morgan TM, Siddiqui J, Martin R, Klein EA, Brittain K, Gotwald P, Barocas DA, Dallmer JR, Gordetsky JB, Steele P, Kundu SD, Stockdale J, Roobol MJ, Venderbos LDF, Sanda MG, Arnold R, Patil D, Evans CP, Dall'Era MA, Vij A, Costello AJ, Chow K, Corcoran NM, Rais-Bahrami S, Phares C, Scherr DS, Flynn T, Karnes RJ, Koch M, Dhondt CR, Nelson JB, McBride D, Cookson MS, Stratton KL, Farriester S, Hemken E, Stadler WM, Pera T, Banionyte D, Bianco FJ Jr, Lopez IH, Loeb S, Taneja SS, Byrne N, Amling CL, Martinez A, Boileau L, Gaylis FD, Petkewicz J, Kirwen N, Helfand BT, Xu J, Scholtens DM, Catalona WJ, Witte JS. Jiang Y, et al. HGG Adv. 2022 Jan 13;3(1):100070. doi: 10.1016/j.xhgg.2021.100070. Epub 2021 Nov 19. HGG Adv. 2022. PMID: 34993496 Free PMC article.
Moreover, increasing values of a previously validated 269-variant genetic risk score (GRS) for PC was positively associated with conversion (e.g., comparing the highest to the two middle deciles gave a hazard ratio [HR] = 1.13; 95% Confidence Interval [CI]= 0.94-1.36); whe …
Moreover, increasing values of a previously validated 269-variant genetic risk score (GRS) for PC was positively associated with conversion …
Immunity assessment in the early stages of amyotrophic lateral sclerosis: a study of virus antibodies and lymphocyte subsets.
Provinciali L, Laurenzi MA, Vesprini L, Giovagnoli AR, Bartocci C, Montroni M, Bagnarelli P, Clementi M, Varaldo PE. Provinciali L, et al. Acta Neurol Scand. 1988 Dec;78(6):449-54. doi: 10.1111/j.1600-0404.1988.tb03686.x. Acta Neurol Scand. 1988. PMID: 3265563
No HTLV-I and HIV antibodies were found in any group and no significant differences in antibody distribution to Toxoplasma G, herpes simplex, cytomegalovirus, measles and mumps viruses were evident. ...
No HTLV-I and HIV antibodies were found in any group and no significant differences in antibody distribution to Toxoplasma G, herpes …
Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives.
Runnebaum IB, Wang-Gohrke S, Vesprini D, Kreienberg R, Lynch H, Moslehi R, Ghadirian P, Weber B, Godwin AK, Risch H, Garber J, Lerman C, Olopade OI, Foulkes WD, Karlan B, Warner E, Rosen B, Rebbeck T, Tonin P, Dubé MP, Kieback DG, Narod SA. Runnebaum IB, et al. Pharmacogenetics. 2001 Oct;11(7):635-8. doi: 10.1097/00008571-200110000-00010. Pharmacogenetics. 2001. PMID: 11668223
The variant progesterone receptor allele named PROGINS is characterized by an Alu insertion into intron G and two additional mutations in exons 4 and 5. The PROGINS allele codes for a progesterone receptor with increased stability and increased hormone-induced transcriptio …
The variant progesterone receptor allele named PROGINS is characterized by an Alu insertion into intron G and two additional mutation …
Optimization of DNA extraction and PCR protocols for phylogenetic analysis in Schinopsis spp. and related Anacardiaceae.
Mogni VY, Kahan MA, de Queiroz LP, Vesprini JL, Ortiz JP, Prado DE. Mogni VY, et al. Springerplus. 2016 Apr 18;5:477. doi: 10.1186/s40064-016-2118-4. eCollection 2016. Springerplus. 2016. PMID: 27217992 Free PMC article.
The objective of this work was to improve an available DNA isolation method for Schinopsis spp. and other related Anacardiaceae, as well as the PCR protocols for DNA amplification of the chloroplast trnL-F, rps16 and ndhF and nuclear ITS-ETS fragments. The modifications proposed …
The objective of this work was to improve an available DNA isolation method for Schinopsis spp. and other related Anacardiaceae, as well as …